Skip to main content
. 2020 Feb 5;105(4):e1358–e1376. doi: 10.1210/clinem/dgaa049

Figure 3.

Figure 3.

Patient disposition. *One patient in the somapacitan group was randomized but did not receive any trial drug (no reason was provided) and was therefore not included in any analyses. The shaded box represents the main period of the trial. Abbreviations: GH, growth hormone; soma, somapacitan